CTRI/2023/06/054213尚未招募Unknown
Evaluation of Comparative efficacy of Triphlala Grita eye drops along with Shatavari Ksheerapaka versus shatavari Grita eye drops and Shatavari Ksheerapaka systemically in the management of post-menopausal dry eye- A Randomised Control Trial
Dr Ashwini B0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of female gender who have attained menopause either spontaneously or surgically induced, of age between 45 to 65years, with the clinical features of dry eye syndrome with OSDI score between 13 to 32 (mild to moderate), schirmerâ??s test 1 between 5 to 10 mm (mild to moderate) and TBUT in between 5 to 10secs (mild to moderate).
- •2.Those have given written, informed consent to participate in this study.
排除标准
- •Currently taking any of medications or cannot stop taking medication is unsuitable for this clinical trial.
- •2.Any other ocular surface disease and dry eyes associated with syndromes or systemic disease
- •3.Patients on steroids and immune- modulatory/ immunosuppression
研究者
相似试验
尚未招募
3 期
To compare the difference between Triphaladi ointment and Zinc oxide ointment in Ahiputana Napkin rashCTRI/2023/10/059365Mahatma Gandhi Ayurveda College Hospital and Research Centre Hirapur Salod Wardha
尚未招募
4 期
Comparison of Two Different Gels containing Triphala and Chlorhexidine Digluconate Along with Scaling in Treatment Of Patients with gum inflammation â?? A Clinical StudyCTRI/2019/01/017290Dr Snehal Ambhore
尚未招募
3 期
Comparative evaluation of efficacy of triphala, chlorhexidine and betadine mouthwash as a preprocedural rinse in reducing microbial count in dental aerosol: a randomized clinical trial.CTRI/2022/05/042601DR SNEHAL VILAS THAMKE
已完成
不适用
Evaluation of combined effect of Triphala and Aloe vera in patients with Oral Submucous Fibrosis: A Randomized Controlled Trial.CTRI/2022/11/047069Dr Komal Deotale60
已完成
不适用
Evaluation of efficacy of triphala in patients with oral submucous fibrosis: A Randomized Controlled Trial.CTRI/2022/09/045425Dr Komal Deotale60